Griffith University

The Eskitis Institute for Cell and Molecular Therapies investigates novel drug- and cell-based therapies for human diseases in the thematic areas of:

• Cancer
• Infectious diseases
• Neurological diseases

The Institute works towards the development of new strategies to prevent and treat disease with an emphasis on multi-disciplinary research and collaboration within the Institute and with national and international partners. Our research is supported by our unique core resources which include:

• Nature Bank, a collection of over 200,000 optimised natural product fractions derived from a uniquely diverse collection of over 45,000 samples of plants and marine invertebrates.
• Neuro Bank, a collection of well-characterised human olfactory neurosphere-derived (hONS) cells from nearly 200 neurology patients.
  
• Queensland Compound Library, a robotic library of pure compounds from Australian chemists numbering more than 330,000.

Nature Bank website now online

We are pleased to announce that the Nature Bank website is now online. Click the banner below to visit the site, search our biota library and read about our natural product drug discovery expertise.

Australian Biodiversity curing Neglected Diseases

Diseases such as malaria, tuberculosis and sleeping sickness disproprtionately affect the world's poorest people, and do not attract the same research effort relative to other diseases that affect western populations, such as heart disease or cancer. At Eskitis we are using the chemical diversity inherent in the natural world to bring the fight to some of the world's most burdensome diseases. We are combining Nature Bank with disease biology expertise, along with synthetic chemistry and drug discovery experience, to identify new compounds that can be developed into cheap but effective drugs for the developing world.